OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Last updated: January 7, 2020
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Active - Recruiting

Phase

N/A

Condition

Brain Tumor

Eye Disorders/infections

Pituitary Disorders

Treatment

N/A

Clinical Study ID

NCT04074642
19-AOI-06
  • Ages > 18
  • All Genders

Study Summary

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • pituitary compressive adenoma (for experimental group)

  • pituitary non compressive adenoma

Exclusion

Exclusion Criteria:

  • retinian disease

  • amblyopia

  • parkinson disease

  • pregnant woman

Study Design

Total Participants: 30
Study Start date:
November 14, 2019
Estimated Completion Date:
July 31, 2022

Connect with a study center

  • CHU de NICE

    Nice, 06000
    France

    Active - Recruiting

  • Hôpital Pasteur 2 - Service d'Ophtalmologie

    Nice, 06001
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.